Sofosbuvir/velpatasvir fixed dose combination for 12 weeks in HCV infected patients previously treated with placebo: Results of the deferred treatment study (GS-US-342-1446 study)

Authors
Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: d2a53ece094887f6abceb801810451ff9bdb08aa
First added on: Feb 07, 2025